From champagne bubbles, dance parties and disease to new nanomaterials

November 22, 2016

WASHINGTON, D.C., Nov. 22, 2016 -- Whether it is clouds or champagne bubbles forming, or the early onset of Alzheimer's disease or Type 2 diabetes, a common mechanism is at work: nucleation processes.

Nucleation processes are a first step in the structural rearrangement involved in the phase transition of matter: a liquid morphing into a gas, a gas becoming a liquid and so on. Clouds, boiling water, bubbles, and some disease stages are all characterized by the formation of a new thermodynamic phase which requires some of the smallest units of the new structure to form before this new phase can grow. Understanding this process is critical for preventing, halting or treating cases of nucleation processes gone wrong -- such as in human disease. Now, a team of researchers from University College London and the University of Cambridge in Great Britain in collaboration with Harvard University have made headway toward understanding this problem from a molecular point of view in a new study. Their finding is significant across an array of phenomena, from human disease to nanotechnology.

"Perhaps an intuitive example of nucleation would be the way in which a quiet dinner party suddenly transforms into a dancing one; such a transition usually requires several people to start dancing at once, acting as a 'nucleus' around which the dancing party assembles," explained An?ela Šari?, lead coauthor at the University College London and the University of Cambridge. The results of this study will appear this week in The Journal of Chemical Physics, from AIP Publishing.

"As commonly observed, if this group of dancers is too small, it tends to be ignored; however, above a certain size, this dancing nucleus attracts more and more people, eventually dominating the room," adds Thomas Michaels, the other lead coauthor. This minimum number of dancing people required to transform the party is what in thermodynamic terms is commonly known as the "critical nucleus."

In their research, the team considers a particularly intriguing example of a nucleated process: the formation of protein filaments. Many filamentous structures of proteins such as actin and tubulin are key for the growth, structural formation, movement and division of cells. They are an essential characteristic of living systems. However, protein filaments can also be disease-causing: Over 50 common disorders, including Alzheimer's disease, Parkinson's disease, and Type 2 diabetes, are associated with the formation and deposition in the brain or other organs of protein filaments commonly known as amyloids.

Using a combination of theory and computer simulations the authors explored the nucleation of protein filaments. Their goal was to establish the fundamental physical principles behind it. Their results showed that a seemingly complicated process of fibril nucleation is actually governed by a relatively simple physical mechanism: Unorganized clusters of proteins -- so-called oligomers -- are formed initially.

These structures do not resemble protein filaments yet, but have to undergo a structural conversion before they can grow into mature filaments, Šari? explained. They found that among many different steps in fibril nucleation, the shape change inside oligomers is the rate-determining step. Therefore, conformational changes in the protein inside oligomers (leading to the formation of β-sheet configurations) are crucial to understand fibril nucleation. Previously, the size of critical nucleus was considered the rate-determining factor.

The study represents an important step forward in the mechanistic understanding of the way in which protein filaments form. Such an understanding is key for studying the early stages in the onset of diseases associated with protein aggregation, as oligomers are increasingly believed to be the prime cause for cellular toxicity.

"Understanding which microscopic-level steps are determining for the formation of protein fibrils can provide invaluable information for designing rational therapies aimed at suppressing pathogenic oligomer generation," Šari? explained

Moreover, due to their unique physicochemical properties, protein filaments are finding extensive applications in materials science as biomaterials for nanotechnology," Michaels said. "Better control of filamentous growth would benefit the production of novel functional materials that have extensive applications in materials science as biomaterials for nanotechnology."
The article, "Kinetics of spontaneous filament nucleation via oligomers: Insights from theory and simulation," is authored by An?ela Šari?, Thomas C. T. Michaels, Alessio Zaccone, Tuomas P.J. Knowles and Daan Frenkel. The article will appear in the journal The Journal of Chemical Physics on Nov. 22, 2016 (DOI: 10.1063/1.4965040). After that date, it can be accessed at


The Journal of Chemical Physics publishes concise and definitive reports of significant research in the methods and applications of chemical physics. See

American Institute of Physics

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to